CHENGDU,
China, Dec. 27, 2024 /PRNewswire/ -- BGM
Group Ltd. (Nasdaq: BGM) (the "Company" or "BGM"), a leading global
pharmaceutical enterprise, today announced completion of the
acquisition of the intelligent platform of AIX Inc. It marks BGM's
official entry into the domains of AI intelligent technology and
financial/insurance services, opening up new opportunities for the
integrated development of healthcare, pharmaceuticals, and
insurance on a global scale.
Through the acquisition of RONS Technology and Xinbao
Investment, BGM will be able to integrate resources in intelligent
technology and biopharmaceuticals, strengthening its market
competitiveness at the intersection of healthcare technology and
insurance technology. This will enable the Company to offer more
comprehensive and intelligent health and insurance service
solutions to users, while simultaneously pioneering the synergistic
development of 'healthcare, pharmaceuticals, and insurance' on a
global scale, further enhancing its global influence.
Mr. Chen Xin, CEO of BGM, stated:
"This transaction represents a pivotal step in our strategic
expansion into the AI insurance and healthcare sectors. The growing
global aging population and increasing healthcare demands present
significant market opportunities for our collaboration. Through
this strategic deal, we will not only strengthen our technological
competitiveness but also accelerate innovation in the healthcare
industry. We are confident about the future and look forward to
partnering with AIX to create a brighter tomorrow."
Mr. Yinan Hu, Vice Chairman and
CEO of AIX, commented: "The transaction marks a significant
milestone in our strategic positioning within the AI-driven
insurance and healthcare sectors. This collaboration will be a
win-win for both parties. We firmly believe that the deep
integration of AI technology with the insurance and healthcare
industries will bring unprecedented opportunities to the market. By
further strengthening our strategic partnership with BGM, we will
be able to leverage its leading position in the global healthcare
sector, to drive innovation, and create new market value. Building
on this foundation, we look forward to joining forces to explore
and expand into new business areas in the future."
Through this acquisition, BGM will be able to fully leverage its
extensive expertise in intelligence technology to enhance its own
digital and intelligent capabilities. This will not only strengthen
its technological competitiveness but also better position it to
adapt to the evolving trends in the pharmaceutical industry. This
strategic move further solidifies its leading position in the
industry.
View original
content:https://www.prnewswire.com/news-releases/bmg-completed-acquisition-of-high-quality-assets-marking-a-new-chapter-in--diversified-growth-302339623.html
SOURCE BGM Group Ltd